A laboratory study found mineralization-related changes after exposing a porcine pulp-derived cell line to midazolam. It did not demonstrate tooth repair from clinical sedation.
Investigators cultured PPU-7 cells with midazolam alone and with selected growth factors. They measured alkaline phosphatase, differentiation-related gene expression, nodule proteins, and mineral crystal characteristics.
Midazolam-only exposure increased several odontoblast-related measures and produced mineralized nodules containing dentin-associated protein. Crystal analysis suggested similarities to hydroxyapatite relevant to dentin.
A cultured porcine cell line is not a functioning human tooth with its vascular, neural, microbial, and mechanical environment. Marker expression and mineral deposition do not establish durable repair, restoration quality, or pain relief.
The study did not establish a clinically deliverable concentration, long-term local safety, or whether systemic sedative exposure achieves the same tissue conditions. A proposed repositioning application remains a research hypothesis.
This paper illustrates that a familiar sedative can be studied for effects beyond behavior. It cannot support a claim that receiving midazolam during dentistry regenerates dentin or that a laboratory differentiation response negates the drug’s established sedative effects in a patient.
Original analysis of the supplied journal article, identified as PMC6387224.